Brian Shayota
Pediatrics · Salt Lake City, UTNPI 1861806523
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $57,261 of the $92,911 with a category attached, or 61.6%. 11 manufacturers reported payments, led by Chiesi USA, Inc. at 35.1% of the total. 2025 is the largest year on record at $58,948, more than ten times the $156 reported in 2019. Among pediatrics clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 122 payments — averaging $761.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Chiesi USA, Inc.$33K
- Sanofi$28K
- Amgen$16K
- Amicus Therapeutics, Inc.$8K
- Travere Therapeutics, Inc.$4K
- Modernatx, Inc.$3K
- plus $683 from 5 others
Across 37 payments — averaging $7926.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ultragenyx Pharmaceutical Inc.$142K
- Modernatx, Inc.$121K
- Takeda Pharmaceuticals U.S.A., Inc.$30K
What the payments were for
- Consulting fees$15,82117%
- Speaking & faculty fees$57,26162%
- Travel & lodging$16,23617%
- Food & beverage$3,4434%
- Education$1500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Chiesi USA, Inc. | 37 | $32,600 |
| Sanofi | 20 | $28,353 |
| Amgen(2 entities) | 29 | $15,703 |
| Amicus Therapeutics, Inc. | 5 | $7,967 |
| Travere Therapeutics, Inc. | 5 | $4,227 |
| Modernatx, Inc. | 13 | $3,377 |
| Biomarin Pharmaceutical Inc. | 4 | $249 |
| Shire North American Group Inc | 1 | $156 |
| Ultragenyx Pharmaceutical Inc. | 5 | $150 |
| Intrabio Inc | 2 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$92,911 in reported general payments places this provider in the 95th percentile of 439 pediatrics providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CerdelgaEliglustat Tartrate | 12 | $377,685 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| SanofiCerdelga | $28,353 | $377,68512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 439 pediatrics providers in Utah.
Other pediatrics in Salt Lake City
- Ashley AndrewsSalt Lake City$31K
- Michael JensenSalt Lake City$18K
- Dominic CamperchioliSalt Lake City$8K
- Jeffrey BotkinSalt Lake City$8K
- Peter LindgrenSalt Lake City$8K
- Arvind HoskoppalSalt Lake City$5K
- Katherine WardSalt Lake City$4K
- Kenneth BroadbentSalt Lake City$4K
- Sara ShobinSalt Lake City$3K
- Abbey BentleySalt Lake City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.